Biology Reference
In-Depth Information
SH-SY5Y and pheochromocytoma PC-12
cells. Cell Signal 19:634-645
97. Zhang L, Chopp M, Zhang RL, Wang L,
Zhang J, Wang Y, Toh Y, Santra M, Lu M,
Zhang ZG (2010) Erythropoietin amplifies
stroke-induced oligodendrogenesis in the rat.
PLoS One 5:e11016
98. Cho YK, Kim G, Park S, Sim JH, Won YJ,
Hwang CH, Yoo JY, Hong HN (2012)
Erythropoietin promotes oligodendrogenesis
and myelin repair following lysolecithin-
induced injury in spinal cord slice culture.
Biochem Biophys Res Commun 417:753-759
99. Genc K, Genc S, Baskin H, Semin I (2006)
Erythropoietin decreases cytotoxicity and
nitric oxide formation induced by
inflammatory stimuli in rat oligodendrocytes.
Physiol Res 55:33-38
100. Digicaylioglu M, Lipton SA (2001)
Erythropoietin-mediated neuroprotection
involves cross-talk between Jak2 and
NF-kappaB signalling cascades. Nature
412:641-647
101. Marrero MB, Venema RC, Ma H, Ling BN,
Eaton DC (1998) Erythropoietin receptor-
operated Ca2+ channels: activation by phos-
pholipase
108. Villa P, Bigini P, Mennini T, Agnello D,
Laragione T, Cagnotto A, Viviani B,
Marinovich M, Cerami A, Coleman TR, Brines
M, Ghezzi P (2003) Erythropoietin selectively
attenuates cytokine production and
inflammation in cerebral ischemia by targeting
neuronal apoptosis. J Exp Med 198:971-975
109. Ehrenreich H, Bartels C, Sargin D, Stawicki
S, Krampe H (2008) Recombinant human
erythropoietin in the treatment of human
brain disease: focus on cognition. J Ren Nutr
18:146-153
110. Wang CH, Liang CL, Huang LT, Liu JK,
Hung PH, Sun A, Hung KS (2004) Single
intravenous injection of naked plasmid DNA
encoding erythropoietin provides neuropro-
tection in hypoxia-ischemia rats. Biochem
Biophys Res Commun 314:1064-1071
111. Malhotra S, Savitz SI, Ocava L, Rosenbaum
DM (2006) Ischemic preconditioning is medi-
ated by erythropoietin through PI-3 kinase
signaling in an animal model of transient isch-
emic attack. J Neurosci Res 83:19-27
112. Prass K, Scharff A, Ruscher K, Lowl D,
Muselmann C, Victorov I, Kapinya K, Dirnagl
U, Meisel A (2003) Hypoxia-induced stroke
tolerance in the mouse is mediated by eryth-
ropoietin. Stroke 34:1981-1986
113. Iwai M, Stetler RA, Xing J, Hu X, Gao Y,
Zhang W, Chen J, Cao G (2010) Enhanced
oligodendrogenesis and recovery of neuro-
logical function by erythropoietin after neo-
natal hypoxic/ischemic brain injury. Stroke
41:1032-1037
114. McPherson RJ, Juul SE (2010) Erythropoietin
for infants with hypoxic-ischemic encephal-
opathy. Curr Opin Pediatr 22:139-145
115. Kumral A, Tuzun F, Oner MG, Genc S,
Duman N, Ozkan H (2011) Erythropoietin
in neonatal brain protection: the past, the
present and the future. Brain Dev
33:632-643
116. Mammis A, McIntosh TK, Maniker AH
(2009) Erythropoietin as a neuroprotective
agent in traumatic brain injury review. Surg
Neurol 71:527-531, discussion 531
117. Agnello D, Bigini P, Villa P, Mennini T,
Cerami A, Brines ML, Ghezzi P (2002)
Erythropoietin exerts an anti-inflammatory
effect on the CNS in a model of experimental
autoimmune encephalomyelitis. Brain Res
952:128-134
118. Zhang J, Li Y, Cui Y, Chen J, Lu M, Elias SB,
Chopp M (2005) Erythropoietin treatment
improves neurological functional recovery in
EAE mice. Brain Res 1034:34-39
119. Celik M, Gokmen N, Erbayraktar S,
Akhisaroglu M, Konakc S, Ulukus C, Genc S,
C-gamma
1.
Kidney
Int
53:1259-1268
102. Kawakami M, Iwasaki S, Sato K, Takahashi M
(2000) Erythropoietin inhibits calcium-
induced neurotransmitter release from clonal
neuronal cells. Biochem Biophys Res Commun
279:293-297
103. Souvenir R, Fathali N, Ostrowski RP, Lekic T,
Zhang JH, Tang J (2011) Tissue inhibitor of
matrix metalloproteinase-1 mediates erythro-
poietin-induced neuroprotection in hypoxia
ischemia. Neurobiol Dis 44:28-37
104. Chen ZY, Wang L, Asavaritkrai P, Noguchi
CT (2010) Up-regulation of erythropoietin
receptor by nitric oxide mediates hypoxia pre-
conditioning. J Neurosci Res 88:3180-3188
105. Keswani SC, Bosch-Marce M, Reed N, Fischer
A, Semenza GL, Hoke A (2011) Nitric oxide
prevents axonal degeneration by inducing HIF-
1-dependent expression of erythropoietin. Proc
Natl Acad Sci U S A 108:4986-4990
106. Belayev L, Saul I, Busto R, Danielyan K,
Vigdorchik A, Khoutorova L, Ginsberg MD
(2005) Albumin treatment reduces neuro-
logical deficit and protects blood-brain bar-
rier integrity after acute intracortical
hematoma in the rat. Stroke 36:326-331
107. Siren AL, Knerlich F, Poser W, Gleiter CH,
Bruck W, Ehrenreich H (2001) Erythropoietin
and erythropoietin receptor in human isch-
emic/hypoxic brain. Acta Neuropathol
101:271-276
Search WWH ::
Custom Search